Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 12,636 | 12,476 | 13,654 | 12,852 | 7,899 |
| Cost of Goods | 9,666 | 9,394 | 10,400 | 9,722 | 6,574 |
| Gross Profit | 2,970 | 3,082 | 3,254 | 3,130 | 1,325 |
| Operating Expenses | 5,133 | 12,006 | 4,422 | 4,112 | 3,327 |
| Operating Income | -1,497 | -8,530 | -768 | -260 | -1,428 |
| Interest Expense | 892 | 2,552 | 594 | 440 | 300 |
| Other Income | 476 | 1,470 | -652 | 0 | 0 |
| Pre-tax Income | -1,913 | -9,612 | -2,014 | -700 | -1,728 |
| Income Tax | -2 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -1,911 | -16,788 | -2,014 | -700 | -1,728 |
| Net Income | $-1,915 | $-16,788 | $-2,014 | $-700 | $-1,728 |
| EPS Basic Total Ops | -0.21 | -3.17 | -0.35 | -0.13 | -0.47 |
| EPS Basic Continuous Ops | -0.20 | -3.17 | -0.35 | -0.13 | -0.33 |
| EPS Diluted Total Ops | -0.21 | -3.17 | -0.35 | -0.13 | -0.47 |
| EPS Diluted Continuous Ops | -0.20 | -3.17 | -0.35 | -0.13 | -0.33 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.68 | -0.35 | -0.13 | -0.47 |
| EBITDA(a) | $-962 | $-6,565 | $-399 | $-146 | $-1,312 |